Base-catalysed C-2 epimerization of ent-fisetinidol-(4â,8)-
catechin tetra-O-methyl ether 20 in the presence of toluene-á-
thiol
4β-ol 3 (52 mg) were dissolved in 0.1 HCl (30 ml) and the
mixture was stirred for 12 h at room temperature under nitro-
gen. The mixture was extracted with ethyl acetate (4 × 50 ml),
the combined organic layers were dried (Na2SO4) and evapor-
ated to dryness. The residual material (145 mg) was methylated
and separated by PLC in benzene–acetone (8:2, v/v) to give two
main bands at RF 0.34 (41 mg) and 0.28 (92 mg). The former
band gave biflavanoid 12. Acetylation of the RF 0.28 band and
PLC in benzene–acetone (8:2, v/v) afforded the epifisetinidol-
(4β,6)-catechin-(8,4α)-fisetinidol derivative 38 with 1H NMR
and CD data identical to those of the same derivative of the
natural profisetinidin 37.
Profisetinidin 20 (1 g) and toluene-α-thiol (790 mg) were dis-
solved in ‘argon degassed’ water (80 ml), the pH of the solu-
tion was adjusted to ca. 12 with 1 NaOH under an argon
atmosphere and the mixture was heated at 90 ЊC for 25 h in a
‘capped’ reaction vial. The mixture was cooled to room tem-
perature and the resulting precipitate was filtered off and thor-
oughly washed with hexanes to remove the excess of toluene-α-
thiol. Separation on Sephadex LH-20 in ethanol–hexane (7:3,
v/v) (3 × 120 cm column, flow rate of 1 ml minϪ1, 16 min frac-
tions) afforded six fractions: A (tubes 26–36, 11 mg), B (46–56,
10.5 mg), C (58–68, 33 mg), D (72–82, 45 mg), E (86–94, 109
mg) and F (95–123, 560 mg). Fraction D was methylated and
purified by PLC in benzene–acetone (7:3, v/v) to give a band
at RF 0.46 (40 mg) which was acetylated and finally purified
by PLC in benzene–acetone (9:1, v/v) to give epifisetinidol-
(4β,8)-catechin hepta-O-methyl ether diacetate 17 (RF 0.30, 40
When the epifisetinidol-(4β,6)-epicatechin biflavanoid 31
(100 mg) and fisetinidol-4α-ol (52 mg) were treated as above, the
unchanged biflavanoid (42 mg) and epifisetinidol-(4β,6)-
epicatechin-(8,4α)-fisetinidol 39 was obtained. The latter was
methylated and purified by PLC in benzene–acetone (7:3, v/v)
to give a band at RF 0.28 (80 mg) which was acetylated and
purified by PLC in benzene–acetone (8:2, v/v) to give the
trimeric profisetinidin derivative 40 (RF 0.35, 73 mg) with iden-
1
mg) with H NMR and CD data identical to the same deriva-
1
tive of the natural profisetinidin 16. Fraction C was similarly
methylated and separated by PLC in benzene–acetone (4:1,
v/v) to give a main band at RF 0.23 (12 mg). This was
acetylated and purified by PLC in benzene–acetone (9:1, v/v)
to give (2R,3S)-2-acetoxy-1-benzylthio-3-(2,4-dimethoxyphenyl)
-3-[(2R,3S)-3-acetoxy-3Ј,4Ј,5,7-tetramethoxyflavan-8-yl]-
propane 23 as a white amorphous solid (RF 0.30, 8 mg)
(Found: Mϩ, 909.3150. C50H53O14S requires M, 909.3156);
δH (Table 3).
tical H NMR and CD to the same derivative of the natural
product 39.
Acknowledgements
Financial support by the Foundation for Research Develop-
ment, Pretoria, the Sentrale Navorsiongsfonds of this Uni-
versity and by the Marketing Committee, Wattle Bark Industry
of South Africa, is acknowledged. The work was also sup-
ported by USDA Competitive Grants 94-03395 and 91-37103-
6492.
Synthesis of di- and tri-meric profisetinidins
Catechin (3 g) and epifisetinidol-4β-ol (500 mg) were dissolved
in 0.1 HCl (200 ml) and the mixture was stirred for 12 h at
room temperature under a nitrogen atmosphere. The mixture
was extracted with ethyl acetate (4 × 200 ml), the combined
organic layers were dried (Na2SO4) and evaporated to dry-
ness. The light-brown residue (3.3 g) was subjected to column
chromatography on Sephadex LH-20 in ethanol (3 × 100 cm
column, flow rate 1 ml minϪ1, 16 min fractions, first 800 ml of
eluent discarded) to give four fractions: A (tubes 112–154, 2.4
g), B (205–270, 545 mg), C (332–370, 184 mg) and D (388–420,
28 mg). Fraction A comprised of catechin, fraction B of
epifisetinidol-(4β,8)-catechin 16, fraction C of epifisetinidol-
References
1 J. J. Botha, D. Ferreira and D. G. Roux, J. Chem. Soc., Perkin Trans.
1, 1981, 1235.
2 D. G. Roux and D. Ferreira, Pure Appl. Chem., 1982, 54, 2465.
3 D. G. Roux and D. Ferreira, Fortschr. Chem. Org. Naturst., 1982, 41,
47.
4 J. J. Botha, P. M. Viviers, D. A. Young, I. C. du Preez, D. Ferreira,
D. G. Roux and W. E. Hull, J. Chem. Soc., Perkin Trans. 1, 1982,
527.
5 P. M. Viviers, J. J. Botha, D. Ferreira, D. G. Roux and H. M.
Saayman, J. Chem. Soc., Perkin Trans. 1, 1983, 17.
6 P. M. Viviers, H. Kolodziej, D. A. Young, D. Ferreira and
D. G. Roux, J. Chem. Soc., Perkin Trans. 1, 1983, 2555.
7 A. Cronjé, J. P. Steynberg, E. V. Brandt, D. A. Young and
D. Ferreira, J. Chem. Soc., Perkin Trans. 1, 1993, 2467.
8 L. J. Porter in The Flavonoids. Advances in Research since 1980, ed.
J. B. Harborne, Chapman and Hall, London, 1988, p. 21; and in
Flavonoids. Advances in Research since 1986, ed. J. B. Harborne,
Chapman and Hall, London, 194, p. 23.
(4β,6)-catechin 29 and fraction
D of bis(epifisetinidol)-
(4β,6:4β,8)-catechin 33. A portion (50 mg) of fraction C was
subjected to consecutive methylation and acetylation. Purifi-
cation by PLC in toluene–ethyl acetate–acetone (7:2:1, v/v, ×2)
of the methyl ether acetate fraction afforded epifisetinidol-
(4β,6)-catechin hepta-O-methyl ether diacetate 30 as a white
amorphous solid (RF 0.38, 40 mg) (Found: Mϩ, 744.2780.
C41H44O13 requires M, 744.2781); δH (Table 3); CD [θ]288 6348,
[θ]243.1 85 080, [θ]234 10 890, [θ]230.5 12 890, [θ]215 Ϫ7279 and [θ]208
5207.
9 E. V. Brandt, D. A. Young, D. Ferreira and D. G. Roux, J. Chem.
Soc., Perkin Trans. 1, 1987, 2353.
Similar treatment of epicatechin (3 g) and epifisetinidol-4β-ol
3 (500 mg) afforded five fractions: A (tubes 50–90, 2.2 g), B
(134–190, 620 mg), C (230–272, 106 mg), D (273–285, 95 mg)
and E (286–305, 15 mg). Fraction A gave epicatechin, frac-
tion B epifisetinidol-(4β,8)-epicatechin 18, fraction C epi-
fisetinidol-(4β,6)-epicatechin 31, fraction E bis(epifisetinidol)-
(4β,6:4β,8)-epicatechin 35 and fraction D a mixture of the
(4β,6)-biflavanoid and triflavanoid 35. A portion of fraction C
(50 mg) was methylated and the resultant crude product
acetylated and separated by PLC in toluene–ethyl acetate–
acetone (7:2:1, v/v, ×2) to give bis(epifisetinidol)-(4β,6:
4β,8)-catechin hepta-O-methyl ether diacetate 33 as a white
amorphous solid (RF 0.29, 36 mg) (Found: Mϩ, 744.2779.
C41H44O13 requires M, 744.2781); δH (Table 3); CD [θ]290.1
Ϫ3066, [θ]243.7 67 580, [θ]234.3 Ϫ2435, [θ]225.5 13 330, [θ]218.2 1532
and [θ]211.6 8871.
10 J. A. Steenkamp, J. C. S. Malan, D. G. Roux and D. Ferreira,
J. Chem. Soc., Perkin Trans. 1, 1988, 1325.
11 J. P. Steynberg, J. F. W. Burger, J. C. S. Malan, A. Cronjé,
D. A. Young and D. Ferreira, Phytochemistry, 1990, 29, 275.
12 J. C. S. Malan, J. A. Steenkamp, J. P. Steynberg, D. A. Young and
D. Ferreira, J. Chem. Soc., Perkin Trans. 1, 1990, 209.
13 J. C. S. Malan, D. A. Young, J. P. Steynberg and D. Ferriera,
J. Chem. Soc., Perkin Trans. 1, 1990, 227.
14 L. Y. Foo, J. Chem. Soc., Chem. Commun., 1986, 236.
15 E. Malan and A. Sireeparsad, Phytochemistry, 1995, 38, 237;
E. Malan, A. Sireeparsad, J. F. W. Burger and D. Ferreira,
Tetrahedron Lett., 1994, 35, 7415.
16 J. A. Parrotta, Southern Forest Experiment Station, Institute of
Tropical Forestry, U.S.D.A. Forest Service, New Orleans, Report
SM-40, 1991.
17 D. G. Roux and E. Paulus, Biochem. J., 1961, 78, 120.
18 S. E. Drewes and D. G. Roux, J. Chem. Soc. (C), 1966, 1644.
19 R. W. Hemingway, L. Y. Foo and L. J. Porter, J. Chem. Soc., Perkin
Trans. 1, 1982, 1209.
Fisetinidol-(4α,8)-catechin 121 (100 mg) and epifisetindol-
J. Chem. Soc., Perkin Trans. 1, 1997
1949